Wednesday, May 12, 2021

A C.D.C. advisory panel recommends the Pfizer-BioNTech vaccine be made available to 12-to-15-year-olds.


By BY APOORVA MANDAVILLI from NYT Health https://ift.tt/33B3aS4
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)